Benefit and risks of aspirin in addition to ticagrelor in acute coronary syndromes: a post hoc analysis of the randomized GLOBAL LEADERS trial

M Tomaniak, P Chichareon, Y Onuma… - … cardiology, 2019 - jamanetwork.com
… Interventions The experimental group received aspirin plusaspirin plus either clopidogrel
(stable coronary artery disease… by 12 months of aspirin alone in the prevention of the primary …

Pros and cons of aspirin for the primary prevention of cardiovascular events: a secondary study of trial sequential analysis

B Zhao, Q Wu, L Wang, C Liao, Y Dong, J Xu… - Frontiers in …, 2021 - frontiersin.org
… Background and Aims: Aspirin leads to substantial benefits … prevention of cardiovascular
disease (CVD). We aimed to cast more light on aspirin’s role for the primary prevention of CVD. …

[PDF][PDF] The efficacy and safety of clopidogrel and aspirin in coronary heart disease with angina pectoris: a systematic review and meta-analysis

CY Tian, Y Huang, X Sun, R Guo, YY Guan… - Asian Toxicol …, 2020 - tmrjournals.com
… Primary prevention of coronary heart disease: integration of new data, evolving views, revised
goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel …

Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: a population-based case-cohort study in Taiwan

YS Wong, CF Tsai, YH Hsu, CT Ong - PloS one, 2020 - journals.plos.org
preventing ischemic stroke, myocardial infarction, and death related to vascular disease
than aspirin … stroke risk between the aspirin and clopidogrel groups among patients with …

Antithrombotics: from aspirin to DOACs in coronary artery disease and atrial fibrillation (Part 3/5)

FWA Verheugt, JM Ten Berg, RF Storey… - … College of Cardiology, 2019 - jacc.org
… Both have been extensively tested in the secondary prevention of coronary artery disease
(… Thus, for ACS patients with AF managed invasively, aspirin and clopidogrel in combination …

The role of clopidogrel in 2020: a reappraisal

G Patti, G Micieli, C Cimminiello… - Cardiovascular …, 2020 - Wiley Online Library
… of treatment and secondary prevention of cardiovascular disease (CVD), including acute …
aspirin to clopidogrel in high-risk patients did not significantly reduce major vascular events and …

P2Y12 inhibitors versus aspirin monotherapy for long-term secondary prevention of atherosclerotic cardiovascular disease events: a systematic review and meta …

A Al-Abdouh, W Abusnina, M Mhanna… - … problems in cardiology, 2022 - Elsevier
… Seven RCTs encompassing 56,982 patients were included in this study (Fig 1). 13, … plus
aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel

Dual antiplatelet therapy versus aspirin in patients with stroke or transient ischemic attack: meta-analysis of randomized controlled trials

K Bhatia, V Jain, D Aggarwal, M Vaduganathan… - 2021 - Am Heart Assoc
… a lower risk of major adverse cardiovascular events (RR, 0.76 [… for the prevention of recurrent
stroke in patients with minor … of clopidogrel to aspirin versus aspirin monotherapy, whereas …

Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events

D Calderone, S Ingala, MS Mauro… - … of Cardiovascular …, 2021 - Taylor & Francis
… to prevent one serious vascular event of 1,429 and 67 patients for primary and secondary
ASCVD prevention… trial, DAPT with aspirin and clopidogrel was compared with aspirin alone in …

Risks of adverse events for users of proton‐pump inhibitors plus aspirin or clopidogrel in patients with aspirin‐related ulcer bleeding

SC Yang, CK Wu, WC Tai, CM Liang… - … and Hepatology, 2021 - Wiley Online Library
cardiovascular event (MACE), UGIB, and mortality between aspirin and clopidogrel in patients
… popular for patients with CVD in the prevention of vascular events and gastrointestinal …